Clinical Trials Directory

Trials / Completed

CompletedNCT01137396

Modafinil, Sleep Architecture and Cocaine Relapse

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
114 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The medication modafinil has been shown to reduce cocaine use in some cocaine users. The investigators have shown that modafinil taken in the morning improves sleep in chronic cocaine users. The investigators hypothesize that the beneficial effects of modafinil in reducing cocaine use may be related to specific effects modafinil has on sleep. This study will measure sleep and cocaine use in cocaine dependent persons who are trying to stop using cocaine, and will test the connection between modafinil's effects on sleep and cocaine use.

Conditions

Interventions

TypeNameDescription
DRUGModafinilModafinil 400mg PO QDaily following up-titration for \~8weeks
BEHAVIORALCognitive Behavioral TherapyOnce weekly cognitive behavioral therapy for cocaine dependence

Timeline

Start date
2010-04-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2010-06-04
Last updated
2016-04-27
Results posted
2016-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01137396. Inclusion in this directory is not an endorsement.

Modafinil, Sleep Architecture and Cocaine Relapse (NCT01137396) · Clinical Trials Directory